Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × INDUSTRY × Dysplastic Nevus Syndrome × Clear all

Status

Completed 3 Unknown 1

Sponsor Class

OTHER 2 INDUSTRY 1

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 162 Carcinoma, Non-Small-Cell Lung 152 Breast Neoplasms 151 Colorectal Neoplasms 89 Stomach Neoplasms 74 Prostatic Neoplasms 66 Pancreatic Neoplasms 66 Lung Neoplasms 65 Melanoma 60 Neoplasm Metastasis 59 Recurrence 58 Multiple Myeloma 57 Leukemia, Myeloid, Acute 57 Carcinoma, Hepatocellular 57 Ovarian Neoplasms 54 Advanced Solid Tumor 52 Lymphoma 47 Advanced Solid Tumors 47 Solid Tumor 44 Uterine Cervical Neoplasms 38 Glioblastoma 37 Lymphoma, Non-Hodgkin 36 Colonic Neoplasms 35 Lymphoma, B-Cell 33 Leukemia 33 Head and Neck Neoplasms 28 Esophageal Neoplasms 28 Urinary Bladder Neoplasms 26 Precursor Cell Lymphoblastic Leukemia-Lymphoma 26 Lymphoma, Follicular 26

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06246903 2024-02-07

INTER-PATHOLOGIST READER STUDY

Orlucent, Inc

Dysplastic Nevus Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡